Skip to main content
. 2021 Apr 6;9(4):388. doi: 10.3390/biomedicines9040388

Table 1.

Association between PPM1D expression levels and clinical/molecular data across public datasets.

Variable GSE6891 [48] (n = 499) GSE13159 [49] (n = 458) TCGA [50] (n = 178)
PPM1D Median n (%) p-Value PPM1D Median n (%) p-Value PPM1D Median (Min–Max) n (%) p-Value
(Min–Max) (Min–Max)
Age
<60-years 151.6 (83.9–393.3) 417 (84.8) 0.03 NA NA NA 25.6 (15.1–46.7) 92 (51.7) 0.004
≥60-years 146.7 (94.5–234.4) 75 (15.2) 22.6 (14.2–39.4) 86 (48.3)
NA = 7
Cytogenetic group
t(8;21) 169.8 (89.9–318.9) 38 (9.0) 0.185 106.2 (32.6–309.9) 35 (7.6) <0.001 25.7 (22.3–31.7) 7 (4.2) 0.031
inv(16)/t(16;16) 156.3 (95.8–319.7) 42 (10.0) 73.2 (41.4–134.6) 27 (5.9) 27.6 (20.5–38.7) 11 (6.6)
NK 147.5 (83.9–371.3) 171 (40.5) NA 0 23.5 (15.1–46.7) 96 (57.8)
CK 146.4 (97.9–259.7) 34 (8.1) 99.3 (31.5–279.4) 45 (9.8) 24.4 (15.2–39.0) 21 (12.7)
KMT2A-r 139.6 (94.3–256.3) 17 (4.0) 72.2 (28.2–233.4) 29 (6.3) 29.1 (18.3–46.1) 10 (6.0)
Other 143.1 (84.1–393.3) 120 (28.4) NA 0 21.9 (14.2–29.5) 21 (12.7)
Normal/Other * 72.2 (23.4–263.2) 322 (21.8)
NA = 77 NA = 12
FLT3-ITD
FLT3-ITD+ 146.1 (87.6–371.3) 134 (26.9) 0.017 NA NA NA 24.2 (14.2–46.7) 32 (18.4) 0.87
FLT3-ITD 152.2 (83.9–393.3) 365 (73.1) 23.2 (15.2–39.0) 143 (81.7)
NA = 3
NPM1 status
NPM1-mut 143.1 (83.9–371.3) 159 (39.9) 0.002 NA NA NA 23.7 (16.1–46.7) 53 (30.3) 0.69
NPM1-wt 155.8 (84.1–393.3) 340 (68.1) 24.0 (14.2–46.1) 122 (69.7)
NA = 3

The sum does not add up to the total due to missing values. * “NK” and “other” cytogenetic subgroups were not distinguished in GSE13159. CK: complex karyotype; ITD: internal tandem duplication; KMT2A-r: KMT2A-rearranged; min-max: minimum-to-maximum value; mut: mutated; NA: not available; NK: normal karyotype; wt: wildtype.